# FDA recall D-0866-2020

> **Lupin Pharmaceuticals Inc.** · Class II · drug recall initiated 2020-02-19.

## Product

Desoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD

## Reason for recall

Failed Impurities/Degradation Specification; high out of specification results observed

## Distribution

Product was distributed throughout the United States.

## Key facts

- **Recall number:** D-0866-2020
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-02-19
- **Report date:** 2020-03-11
- **Termination date:** 2021-06-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0866-2020

## Citation

> AI Analytics. FDA recall D-0866-2020. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0866-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*